Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Arlington Heights, Illinois 60005


The objective of the study is to evaluate the long-term clinical utility, safety, and effectiveness of re-treatment with the TearCare™ System in adult patients with dry eye syndrome who had previously been treated with the TearCare System.


Inclusion Criteria: - Previously enrolled in the TearCare arm of the TearCare Pilot Study - Reports dry eye symptoms within 3 months of the baseline examination with a Standard Patient Evaluation for Dryness (SPEED) score ≥ 6 - TBUT of <10 seconds in at least one eye - Willing to comply with the study, procedures, and follow-up - Willing and able to provide consent Exclusion Criteria: - Any active ocular or peri-ocular infection or inflammation - Recurrent eye inflammation within the past 3 months - Ocular surgery, oculoplastic surgery, ocular injury, Ocular Herpes Simplex, or Herpes Zoster - Ocular surface abnormalities that may affect tear film distribution or treatment - Abnormal eyelid function in either eye - Diminished or abnormal facial, periocular, ocular or corneal sensation - Ocular surface abnormalities such as corneal epithelial defects, ulcers, corneal dystrophies - Systemic diseases resulting in dry eye (e.g. Sjogren's syndrome) - Allergies to silicone tissue adhesives - An absence or fibrosis of the Meibomian glands (e.g. ectodermal dysplasia). - Unwillingness to abstain for the duration of the study from systemic medication known to cause ocular dryness (e.g. Accutane, antihistamines, etc.) - Anyone who requires chronic use (i.e. for any portion of the study) of topical ophthalmic antibiotics, steroids, non-steroidal anti-inflammatory medications or who has been on any of these medications within the past 30 days. - Unwillingness to washout and remain off certain dry eye medications for the duration of the study. - Participation in another ophthalmic clinical trial within the past 30 days - Co-existing conditions that could interfere with the assessment of safety or efficacy of treatment (e.g. macular disease, pregnancy, nursing, etc.)



Primary Contact:


Backup Contact:


Location Contact:

Arlington Heights, Illinois 60005
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: February 04, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.